T 3788

Drug Profile

T 3788

Alternative Names: M 5010; M 5011; M 5011C; S-MTPPA

Latest Information Update: 25 May 2001

Price : $50

At a glance

  • Originator Maruho
  • Developer Maruho; Toyama Chemical
  • Class Analgesics; Antipyretics; Antirheumatics; Nonsteroidal anti-inflammatories
  • Mechanism of Action Cyclooxygenase inhibitors; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Inflammation; Pain; Postmenopausal osteoporosis

Most Recent Events

  • 25 May 2001 Discontinued-III for Pain in Japan (PO)
  • 25 May 2001 Discontinued-Preclinical for Postmenopausal osteoporosis in Japan (PO)
  • 25 May 2001 Discontinued-III for Inflammation in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top